MedGenome’s OncoMD helps analyze Genetic Alterations in Mesothelioma – Paper published in Nature Genetics

Mesothelioma is a relatively rare cancer with a five year survival rate between five and ten percent. The global death due to Mesothelioma is estimated to be ~43,000 per year.